0001628280-25-029979.txt : 20250606 0001628280-25-029979.hdr.sgml : 20250606 20250606160539 ACCESSION NUMBER: 0001628280-25-029979 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20250605 FILED AS OF DATE: 20250606 DATE AS OF CHANGE: 20250606 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Bisaro Paul CENTRAL INDEX KEY: 0001237253 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-26642 FILM NUMBER: 251030581 MAIL ADDRESS: STREET 1: 10 SYLVAN WAY CITY: PARSIPPANY STATE: NJ ZIP: 07054 FORMER NAME: FORMER CONFORMED NAME: BISARO PAUL DATE OF NAME CHANGE: 20030530 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MYRIAD GENETICS INC CENTRAL INDEX KEY: 0000899923 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] ORGANIZATION NAME: 03 Life Sciences EIN: 870494517 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 322 NORTH 2200 WEST CITY: SALT LAKE CITY STATE: UT ZIP: 84116 BUSINESS PHONE: 801-584-3600 MAIL ADDRESS: STREET 1: 322 NORTH 2200 WEST CITY: SALT LAKE CITY STATE: UT ZIP: 84116 4 1 wk-form4_1749240326.xml FORM 4 X0508 4 2025-06-05 0 0000899923 MYRIAD GENETICS INC MYGN 0001237253 Bisaro Paul 322 NORTH 2200 WEST SALT LAKE CITY UT 84116 1 0 0 0 0 Common Stock 2025-06-05 4 A 0 49796 0 A 89941 D Consists of restricted stock units granted pursuant to Myriad Genetics, Inc.'s 2017 Employee, Director and Consultant Equity Incentive Plan, as amended. Each restricted stock unit represents a contingent right to receive one share of common stock and vests upon the earlier of (a) the first anniversary of the date of grant or (b) the date of the next annual meeting of stockholders following such grant. By: Justin Hunter For: Paul Bisaro 2025-06-06